Publications by authors named "Luwen Mu"

Claim this Profile
L
LI-RADS categories and clinicopathological features predict recurrence-free survival in patients with radical resected hepatocellular carcinoma.
Sue Cao, Luwen Mu, Jianwen Li, Jie Zhang, Feng Chen

Eur J Radiol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TACE Sequential to Radiofrequency Ablation versus RFA Alone in Hepatocellular Carcinoma Within Milan Criteria.
Huzheng Yan, Chenghao Zhao, Mingming Liu, Huan Liu, Luwen Mu

J Hepatocell Carcinoma· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combining immune checkpoint inhibitors and molecular-targeted agents with hepatic arterial infusion chemotherapy for hepatocellular carcinoma with inferior vena cava and/or right atrium tumor thrombus.
Suixing Zhong, Junzhe Yi, Song Chen, Xiaoyan Mo, Qifeng Chen, Luwen Mu

Hepatol Int· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Idarubicin-transarterial chemoembolization combined with gemcitabine plus cisplatin for unresectable intrahepatic cholangiocarcinoma.
Cheng-Hao Zhao, Huan Liu, Tao Pan, Zhan-Wang Xiang, Lu-Wen Mu

World J Gastrointest Oncol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical outcomes of modified transarterial chemoembolization vs. drug-eluting bead transarterial chemoembolization as initial treatment for single hepatocellular carcinoma: a propensity score matching analysis.
Boyang Chang, Churen Zhou, Chengcheng Liu, Luwen Mu, Mingsheng Huang

Ann Med· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TACE Combined with Lenvatinib and Camrelizumab for Unresectable Multiple Nodular and Large Hepatocellular Carcinoma (>5 cm).
Zhanwang Xiang, Guohong Li, Luwen Mu, Haofan Wang, Churen Zhou

Technol Cancer Res Treat· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediction of effective percutaneous transhepatic biliary drainage in patients with hepatocellular carcinoma: A multi-central retrospective study.
Haofan Wang, Yitao Mao, Chunning Zhang, Xiaojun Hu, Bin Chen, Luwen Mu

Liver Res· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Arterial Chemotherapy of Oxaliplatin Plus Fluorouracil Versus Sorafenib in Advanced Hepatocellular Carcinoma: A Biomolecular Exploratory, Randomized, Phase III Trial (FOHAIC-1).
Ning Lyu, Xun Wang, Ji-Bin Li, Jin-Fa Lai, Qi-Feng Chen, Lu-Wen Mu

J Clin Oncol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Imaging features of gadoxetic acid-enhanced MR imaging for evaluation of tumor-infiltrating CD8 cells and PD-L1 expression in hepatocellular carcinoma.
Lin Sun, Luwen Mu, Jing Zhou, Wenjie Tang, Linqi Zhang

Cancer Immunol Immunother· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Clinical Value of Computed Tomography (CT)-Guided I Brachytherapy for Locally Advanced Non-Small Cell Lung Cancer After Progression of Concurrent Radiochemotherapy.
Zhanwang Xiang, Zhihui Zhong, Luwen Mu, Guohong Li, Churen Zhou

Cancer Manag Res· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Ablation Reboots the Response in Advanced Hepatocellular Carcinoma With Stable or Atypical Response During PD-1 Therapy: A Proof-of-Concept Study.
Ning Lyu, Yanan Kong, Xiaoxian Li, Luwen Mu, Haijing Deng

Front Oncol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Follow-up schedule for initial recurrent hepatocellular carcinoma after ablation based on risk classification.
Xuqi Sun, Lingling Li, Ning Lyu, Luwen Mu, Jinfa Lai

Cancer Imaging· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual Vascular Endothelial Growth Factor Receptor and Fibroblast Growth Factor Receptor Inhibition Elicits Antitumor Immunity and Enhances Programmed Cell Death-1 Checkpoint Blockade in Hepatocellular Carcinoma.
Haijing Deng, Anna Kan, Ning Lyu, Luwen Mu, Yi Han

Liver Cancer· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival benefits of computed tomography-guided thermal ablation for adrenal metastases from hepatocellular carcinoma.
Ning Lyu, Yanan Kong, Tao Pan, Luwen Mu, Xuqi Sun

Int J Hyperthermia· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stent placement with iodine-125 seeds strand effectively extends the duration of stent patency and survival in patients with unresectable malignant obstructive jaundice.
Tao Pan, Ming-An Li, Lu-Wen Mu, Duo Zhu, Jie-Sheng Qian

Scand J Gastroenterol· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chiral ruthenium(II) complex Δ-[Ru(bpy)(o-FMPIP)] (bpy = bipyridine, o-FMPIP = 2-(2'-trifluoromethyphenyl) imidazo[4,5-f][1,10]phenanthroline) as potential apoptosis inducer via DNA damage.
Mingjun Bai, Tao Pan, Gengnan Yu, Qiang Xie, Zhaolin Zeng, Luwen Mu

Eur J Pharmacol· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin in Hepatocellular Cancer with Extrahepatic Spread.
Ning Lyu, Yanan Kong, Tao Pan, Luwen Mu, Shaolong Li

J Vasc Interv Radiol· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanism and prognostic value of indoleamine 2,3-dioxygenase 1 expressed in hepatocellular carcinoma.
Shaolong Li, Xue Han, Ning Lyu, Qiankun Xie, Haijing Deng, Luwen Mu

Cancer Sci· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CT-guided percutaneous radiofrequency ablation for lung neoplasms adjacent to the pericardium.
Luwen Mu, Tao Pan, Ning Lyu, Lin Sun, Shaolong Li

Lung Cancer· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatic arterial infusion of oxaliplatin plus fluorouracil/leucovorin vs. sorafenib for advanced hepatocellular carcinoma.
Ning Lyu, Yanan Kong, Luwen Mu, Youen Lin, Jibin Li

J Hepatol· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chiral ruthenium(ii) complex as potent radiosensitizer of I through DNA-damage-mediated apoptosis.
Mingjun Bai, Zhaolin Zeng, Li Li, Qiong Wu, Yanyang Zhang, Luwen Mu

RSC Adv· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Percutaneous CT-guided radiofrequency ablation for patients with extrahepatic oligometastases of hepatocellular carcinoma: long-term results.
Luwen Mu, Lin Sun, Tao Pan, Ning Lyu, Shaolong Li

Int J Hyperthermia· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FOXAI: a phase II trial evaluating the efficacy and safety of hepatic arterial infusion of oxaliplatin plus fluorouracil/leucovorin for advanced hepatocellular carcinoma.
Ning Lyu, Youen Lin, Yanan Kong, Zhenfeng Zhang, Longzhong Liu, Luwen Mu

Gut· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of Combined Transcatheter Arterial Chemoembolization and CT-guided Radiofrequency Ablation with Surgical Resection in Patients with Hepatocellular Carcinoma within the Up-to-seven Criteria: A Multicenter Case-matched Study.
Tao Pan, Lu-Wen Mu, Chun Wu, Xi-Qun Wu, Qian-Kun Xie

J Cancer· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Programmed death ligand 1 as an indicator of pre-existing adaptive immune responses in human hepatocellular carcinoma.
Qian-Kun Xie, Yu-Jie Zhao, Tao Pan, Ning Lyu, Lu-Wen Mu, Mu-De Shi

Oncoimmunology· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis